Supreme Court patent docket swells with 13 petitions, two more pending, and major fights over IPR review, eligibility, damages, and claim scope.
The USPTO will close out FY2026 (which ends September 30) with about 320k utility patent grants, down about 3% from FY2025. Although the total is a bit down this year, an interesting shift here is ...
The Federal Circuit has vacated a PTAB obviousness rejection of a catheter claim, holding that the Board's reading of the claim term "flow barrier" was unreasonably broad. In re Incept LLC, No.
As the 2025-2026 term ends, the Supreme Court has agreed to decide whether the strength of a trademark is a question of fact or a question of law. The Court granted certiorari in RiseandShine Corp. v.
The case stems from the dispute between Ericsson and Lenovo over licenses to their respective portfolios of patents essential to the 5G wireless telecommunications standards (standards-essential ...
In a characteristically terse post on X, twitter co-founder Jack Dorsey declared “delete all IP law.” Elon Musk quickly agreed with Dorsey’s statement. It is unclear to me which of these ...
The “optimization” claims of US8842761 and US10693700 are ineligible under § 101; The “constellation” claims of US11019509 and US11018922 are eligible; The infringement verdict stands (denial of JMOL ...
Earlier this week, the USPTO published updated examination guidelines regarding obviousness determinations under 35 U.S.C. §103. While these new guidelines are not legally binding, they offer ...
The Federal Circuit’s en banc decision in EcoFactor v. Google marks a significant tightening of standards for admitting patent damages expert testimony. The court (in an 8–2 split) overturned a $20 ...
A patentable invention needs to be more than simply “new.” Rather, an invention requires a substantial step beyond what was already known in the field. Since 1952, this doctrine has been known as ...
The PTAB concluded “clinically proven effective” was non-limiting, reasoning that because the claims already recited specific dosage amounts (2.5 mg rivaroxaban twice daily and 75-100 mg aspirin daily ...
When do patent attorneys actually file? Not first thing in the morning, and not in a rush at the end of the business day. Across roughly 475,000 USPTO electronic filings May-June 2025, volume climbs ...